Basic Information
LncRNA/CircRNA Name | LINK-A |
Synonyms | LINC01139, LINK-A, LINKA |
Region | GRCh38_1:238480384-238486023 |
Ensemble | ENSG00000215808 |
Refseq | NR_015407 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | non small cell lung cancer |
ICD-0-3 | C34 |
Methods | qPCR, Western blot, other |
Sample | plasma, NSCLC cell lines (H1993, H1581) |
Expression Pattern | up-regulated |
Function Description | Plasma levels of LINK-A were found to be significantly higher in patients with different types of metastatic NSCLC than in patients with non-metastatic NSCLC and healthy controls. Plasma levels of LINK-A were lower in patients with metastatic NSCLC on the day of discharge than on the day of admission. Patients with high plasma LINK-A had a higher mortality rate and lower progression-free survival rate within 2 years of discharge. In conclusion, LINK-A is overexpressed in metastatic NSCLC, and may promote the migration and invasion of NSCLC by activating Akt signaling. |
Pubmed ID | 31404323 |
Year | 2019 |
Title | LINK-A lncRNA Is Upregulated in Metastatic Non-Small Cell Lung Cancer and Is Associated With Poor Prognosis |
External Links
Links for LINK-A | GenBank HGNC NONCODE |
Links for non small cell lung cancer | OMIM COSMIC |